Home>Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG
Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG
- Impact factors: 5.578
- Publication: ACS Infectious Diseases
- Author:Li-rong Mao, Jian-peng Du, Xiao-chun Wang, Li-fa Xu, Yan-peng Zhang, Qi-shan Sun, Zi-lun Shi, Ying-ru Xing, Yi-xin Su, Sheng-jian Wang, Jian Wang, Ji-lei Ma, Jing-yan Zhang
- DOI citation-doi:10.1021/acsinfecdis.2c00570
- Date:2023-02-21